enow.com Web Search

  1. Ads

    related to: new research on schizophrenia treatment

Search results

  1. Results from the WOW.Com Content Network
  2. FDA approves 1st new drug for schizophrenia in more ... - AOL

    www.aol.com/fda-approves-1st-drug-schizophrenia...

    Cobenfy offers new hope for people with schizophrenia, providing an innovative treatment option that could change how this condition is managed, according to Jelena Kunovac, MD, a board-certified ...

  3. FDA approves new type of schizophrenia drug - AOL

    www.aol.com/news/fda-approves-type-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...

  4. FDA Approves the First New Schizophrenia Drug in Decades - AOL

    www.aol.com/lifestyle/fda-approves-first...

    The medicine works in an entirely different way from existing treatments.

  5. Schizophrenia In America - The Huffington Post

    highline.huffingtonpost.com/articles/en/stop-the...

    Among researchers, schizophrenia has long been known as the “graveyard of psychiatric research.” In the 1890s, when the German psychiatrist Emil Kraepelin began coming up with categories of mental illness, he devoted one diagnosis to a peculiar madness that seemed to appear in the late teens and early twenties, a combination of delusions ...

  6. Ulotaront - Wikipedia

    en.wikipedia.org/wiki/Ulotaront

    The Brief Negative Symptom Scale (BNSS) has been used to assess the effect of Ulotaront on the negative symptoms of schizophrenia. [18] In July 2023, the pharmaceutical company behind the drug announced that the drug had failed to outperform placebo in the treatment of acutely psychotic patients with schizophrenia, as measured by the PANSS. [19]

  7. Management of schizophrenia - Wikipedia

    en.wikipedia.org/wiki/Management_of_schizophrenia

    A new first-in-class antipsychotic that targets multiple neurotransmitter systems called lumateperone (ITI-007), was trialed and approved by the FDA in December 2019 for the treatment of schizophrenia in adults. [24] [26] [27] Lumateperone is a small molecule agent that shows improved safety, and tolerance.

  8. Soteria (psychiatric treatment) - Wikipedia

    en.wikipedia.org/.../Soteria_(psychiatric_treatment)

    However, the Soteria Research Project was also the subject of much controversy. [5] One of the main critiques was that the project was withholding evidence-based treatment as it was based on invalid anti-medication and anti-disease models, which went against the widely accepted biopsychosocial model of disease.

  9. Bristol Myers wins US FDA approval for new type of ...

    www.aol.com/news/us-fda-approves-bristol-myers...

    (Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. The ...

  1. Ads

    related to: new research on schizophrenia treatment